6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one

C125H95N23O8S — CID 158726123

IUPAC6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one
SMILESO=c1ccc2cc(-c3coc4ncccc34)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(-c3nc4cccnc4o3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(-c3nc4cccnc4s3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(-c3nc4ncccc4[nH]3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(C3CCC4N=CNC4C3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(C3CCC4NCCCC4C3)c(-c3ccccc3)nc2[nH]1
InChIInChI=1S/C23H25N3O.C21H20N4O.C21H13N3O2.C20H13N5O.C20H12N4O2.C20H12N4OS/c27-21-11-9-18-14-19(16-8-10-20-17(13-16)7-4-12-24-20)22(26-23(18)25-21)15-5-2-1-3-6-15;26-19-9-7-15-10-16(14-6-8-17-18(11-14)23-12-22-17)20(25-21(15)24-19)13-4-2-1-3-5-13;25-18-9-8-14-11-16(17-12-26-21-15(17)7-4-10-22-21)19(24-20(14)23-18)13-5-2-1-3-6-13;26-16-9-8-13-11-14(19-22-15-7-4-10-21-20(15)25-19)17(24-18(13)23-16)12-5-2-1-3-6-12;2*25-16-9-8-13-11-14(19-22-15-7-4-10-21-20(15)26-19)17(24-18(13)23-16)12-5-2-1-3-6-12/h1-3,5-6,9,11,14,16-17,20,24H,4,7-8,10,12-13H2,(H,25,26,27);1-5,7,9-10,12,14,17-18H,6,8,11H2,(H,22,23)(H,24,25,26);1-12H,(H,23,24,25);1-11H,(H,21,22,25)(H,23,24,26);2*1-11H,(H,23,24,25)
InChIKeyIKNGNVLTNPVYDL-UHFFFAOYSA-N
MW2079.35 g/mol
LogP23.43
Rot. Bonds12

About 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one

6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one (PubChem CID 158726123) has the molecular formula C125H95N23O8S and a molecular weight of 2079.35 g/mol. Its IUPAC name is 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one.

Molecular Properties

Compound Name6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one
PubChem CID158726123
Molecular FormulaC125H95N23O8S
Molecular Weight2079.35 g/mol
Exact Mass2077.75
IUPAC Name6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one
SMILESO=c1ccc2cc(-c3coc4ncccc34)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(-c3nc4cccnc4o3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(-c3nc4cccnc4s3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(-c3nc4ncccc4[nH]3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(C3CCC4N=CNC4C3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(C3CCC4NCCCC4C3)c(-c3ccccc3)nc2[nH]1
InChIInChI=1S/C23H25N3O.C21H20N4O.C21H13N3O2.C20H13N5O.C20H12N4O2.C20H12N4OS/c27-21-11-9-18-14-19(16-8-10-20-17(13-16)7-4-12-24-20)22(26-23(18)25-21)15-5-2-1-3-6-15;26-19-9-7-15-10-16(14-6-8-17-18(11-14)23-12-22-17)20(25-21(15)24-19)13-4-2-1-3-5-13;25-18-9-8-14-11-16(17-12-26-21-15(17)7-4-10-22-21)19(24-20(14)23-18)13-5-2-1-3-6-13;26-16-9-8-13-11-14(19-22-15-7-4-10-21-20(15)25-19)17(24-18(13)23-16)12-5-2-1-3-6-12;2*25-16-9-8-13-11-14(19-22-15-7-4-10-21-20(15)26-19)17(24-18(13)23-16)12-5-2-1-3-6-12/h1-3,5-6,9,11,14,16-17,20,24H,4,7-8,10,12-13H2,(H,25,26,27);1-5,7,9-10,12,14,17-18H,6,8,11H2,(H,22,23)(H,24,25,26);1-12H,(H,23,24,25);1-11H,(H,21,22,25)(H,23,24,26);2*1-11H,(H,23,24,25)
InChIKeyIKNGNVLTNPVYDL-UHFFFAOYSA-N
XLogP23.43
TPSA443.22 Ų
H-Bond Donors9
H-Bond Acceptors25
Rotatable Bonds12
Heavy Atoms157
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002079.35
LogP ≤ 523.43
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1025

Analyze 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one?
The IUPAC name of 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one (CID 158726123) is 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one.
What is the SMILES notation for 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one?
The canonical SMILES for 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one is O=c1ccc2cc(-c3coc4ncccc34)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(-c3nc4cccnc4o3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(-c3nc4cccnc4s3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(-c3nc4ncccc4[nH]3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(C3CCC4N=CNC4C3)c(-c3ccccc3)nc2[nH]1.O=c1ccc2cc(C3CCC4NCCCC4C3)c(-c3ccccc3)nc2[nH]1.
What is the InChIKey of 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one?
The InChIKey is IKNGNVLTNPVYDL-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H25N3O.C21H20N4O.C21H13N3O2.C20H13N5O.C20H12N4O2.C20H12N4OS/c27-21-11-9-18-14-19(16-8-10-20-17(13-16)7-4-12-24-20)22(26-23(18)25-21)15-5-2-1-3-6-15;26-19-9-7-15-10-16(14-6-8-17-18(11-14)23-12-22-17)20(25-21(15)24-19)13-4-2-1-3-5-13;25-18-9-8-14-11-16(17-12-26-21-15(17)7-4-10-22-21)19(24-20(14)23-18)13-5-2-1-3-6-13;26-16-9-8-13-11-14(19-22-15-7-4-10-21-20(15)25-19)17(24-18(13)23-16)12-5-2-1-3-6-12;2*25-16-9-8-13-11-14(19-22-15-7-4-10-21-20(15)26-19)17(24-18(13)23-16)12-5-2-1-3-6-12/h1-3,5-6,9,11,14,16-17,20,24H,4,7-8,10,12-13H2,(H,25,26,27);1-5,7,9-10,12,14,17-18H,6,8,11H2,(H,22,23)(H,24,25,26);1-12H,(H,23,24,25);1-11H,(H,21,22,25)(H,23,24,26);2*1-11H,(H,23,24,25).
What are the key properties of 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one?
6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one has a molecular weight of 2079.35 g/mol, XLogP of 23.43, 12 rotatable bonds, 9 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-6-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-(3a,4,5,6,7,7a-hexahydro-3H-benzimidazol-5-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-furo[2,3-b]pyridin-3-yl-7-phenyl-1H-1,8-naphthyridin-2-one;6-(1H-imidazo[4,5-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;6-([1,3]oxazolo[5,4-b]pyridin-2-yl)-7-phenyl-1H-1,8-naphthyridin-2-one;7-phenyl-6-([1,3]thiazolo[5,4-b]pyridin-2-yl)-1H-1,8-naphthyridin-2-one is sourced from PubChem (CID 158726123), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).